Human Genome Epidemiology Literature Finder
Cancer
|
Records 1 - 30 (of 8569 Records) |
| Query Trace: Lung Cancer[original query] |
|---|
| Deep learning based automated epidermal growth factor receptor and anaplastic lymphoma kinase status prediction of brain metastasis in non-small cell lung cancer. Exploration of targeted anti-tumor therapy 2023 9 4 (4): 657-668. Abhishek Mahajan, Gurukrishna B, Shweta Wadhwa, Ujjwal Agarwal, Ujjwal Baid, Sanjay Talbar, Amit Kumar Janu, Vijay Patil, Vanita Noronha, Naveen Mummudi, Anil Tibdewal, J P Agarwal, Subash Yadav, Rajiv Kumar Kaushal, Ameya Puranik, Nilendu Purandare, Kumar Prabha |
| The impact of adjuvant EGFR-TKIs and 14-gene molecular assay on stage I non-small cell lung cancer with sensitive EGFR mutations. EClinicalMedicine 2023 9 64 102205. Yu Jiang, Yuechun Lin, Wenhai Fu, Qihua He, Hengrui Liang, Ran Zhong, Ran Cheng, Bingliang Li, Yaokai Wen, Huiting Wang, Jianfu Li, Caichen Li, Shan Xiong, Songan Chen, Jianxing Xiang, Michael J Mann, Jianxing He, Wenhua Lia |
| Bronchoalveolar Lavage as Potential Diagnostic Specimens to Genetic Testing in Advanced Nonsmall Cell Lung Cancer. Technology in cancer research & treatment 2023 9 22 15330338231202881. Xuwen Lin, Yazhou Cai, Chenyu Zong, Binbin Chen, Di Shao, Hao Cui, Zheng Li, Ping |
| Exploring the molecular features and genetic prognostic factors of pulmonary high-grade neuroendocrine carcinomas. Human pathology 2023 9 . Haiyue Wang, Linghua Yan, Yanli Zhu, Wei Sun, Xin Yang, Xinying Liu, Kaiwen Chi, Xiaozheng Huang, Lixin Zhou, Dongmei L |
| Impact of SPARC expression on treatment response of pembrolizumab and brain metastasis in patients with metastatic non-small cell lung cancer. International immunopharmacology 2023 9 124 (Pt B): 110947. Sabin Goktas Aydin, Ahmet Bilici, Elif Calis, Yasin Kutlu, Jamshid Hamdard, Harun Muglu, Omer Fatih Olmez, Ebru Karci, Ozgur Acikg |
| Large-scale whole exome sequencing studies identify two genes,CTSL and APOE, associated with lung cancer. PLoS genetics 2023 9 19 (9): e1010902. Jingxiong Xu, Wei Xu, Jiyeon Choi, Yonathan Brhane, David C Christiani, Jui Kothari, James McKay, John K Field, Michael P A Davies, Geoffrey Liu, Christopher I Amos, Rayjean J Hung, Laurent Briolla |
| Do patient characteristics affect EGFR tyrosine kinase inhibitor treatment outcomes? A network meta-analysis of real-world survival outcomes of East Asian patients with advanced non-small cell lung cancer treated with first-line EGFR-TKIs. Thoracic cancer 2023 9 . Huang-Chih Chang, Chin-Chou Wang, Chia-Cheng Tseng, Kuo-Tung Huang, Yu-Mu Chen, Yu-Ping Chang, Chien-Hao Lai, Wen-Feng Fang, Meng-Chih Lin, Hung-Yi Chua |
| Path less Traveled: Targeting Rare Driver Oncogenes in Non-Small-Cell Lung Cancer. JCO oncology practice 2023 9 OP2300273. Sun Min Lim, Jii Bum Lee, Yuko Oya, Jorn Nutzinger, Ross S |
| Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer. British journal of cancer 2023 9 . Masayuki Shirasawa, Tatsuya Yoshida, Kouya Shiraishi, Naoko Goto, Shigehiro Yagishita, Tatsuya Imabayashi, Yuji Matsumoto, Ken Masuda, Yuki Shinno, Yusuke Okuma, Yasushi Goto, Hidehito Horinouchi, Masaya Yotsukura, Yukihiro Yoshida, Kazuo Nakagawa, Katsuhiko Naoki, Takaaki Tsuchida, Ryuji Hamamoto, Noboru Yamamoto, Noriko Motoi, Takashi Kohno, Shun-Ichi Watanabe, Yuichiro O |
| The inherited KRAS-variant as a biomarker of Cetuximab Response in NSCLC. Cancer research communications 2023 9 . Joanne B Weidhaas, Chen Hu, Ritsuko Komaki, Gregory A Masters, George R Blumenschein, Joe Y Chang, Bo Lu, Adam P Dicker, Jeffrey A Bogart, Yolanda I Garces, Samir Narayan, Clifford G Robinson, Vivek S Kavadi, Joel S Greenberger, Christopher D Koprowski, James W Welsh, Elizabeth Gore, Robert M MacRae, Rebecca Paulus, Jeffrey Bradl |
| Prevalence of oncogenic driver mutations in Hispanics/Latin patients with lung cancer. A systematic review and meta-analysis. Lung cancer (Amsterdam, Netherlands) 2023 9 185 107378. Rafael Parra-Medina, Juan Pablo Castañeda-González, Luisa Montoya, María Paula Gómez-Gómez, Daniel Clavijo Cabezas, Merideidy Plazas Varg |
| Prognostic and predictive impact of molecular tumor burden index in non-small cell lung cancer patients. Thoracic cancer 2023 9 . Fan Yang, Min Tang, Liang Cui, Jing Bai, Jiangyong Yu, Jiayi Gao, Xin Nie, Xu Li, Xuefeng Xia, Xin Yi, Ping Zhang, Lin |
| Chromosomal Copy Number Variation Predicts EGFR-TKI Response and Prognosis for Patients with Non-Small Cell Lung Cancer. Pharmacogenomics and personalized medicine 2023 9 16 835-846. Haiyan He, Hang Ma, Zhuo Chen, Jingliang Chen, Dandan Wu, Xuedong Lv, Jie Z |
| The efficacy and safety of chemo-free therapy in epidermal growth factor receptor tyrosine kinase inhibitor-resistant advanced non-small cell lung cancer: A single-arm, phase II study. Cancer medicine 2023 9 . Shuyang Zhang, Lu Yang, Yaning Yang, Guangjian Yang, Haiyan Xu, Xueliang Niu, Yan Wa |
| Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health system. European journal of cancer (Oxford, England : 1990) 2023 9 193 113310. Ching-Yao Yang, Jin-Yuan Shih, Wei-Yu Liao, Chao-Chi Ho, Chia-Lin Hsu, Tzu-Hsiu Tsai, Shang-Gin Wu, Yen-Ting Lin, Wei-Hsun Hsu, Suyog Jain, Steve Olsen, James Chih-Hsin Yang, Chong-Jen Yu, Pan-Chyr Ya |
| Associations between longer leukocyte telomere length and increased lung cancer risk among never smokers in urban China. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2023 9 . Jason Yy Wong, Xiao-Ou Shu, Wei Hu, Batel Blechter, Jianxin Shi, Kevin Wang, Richard Cawthon, Qiuyin Cai, Gong Yang, Mohammad L Rahman, Bu-Tian Ji, Yutang Gao, Wei Zheng, Nathaniel Rothman, Qing L |
| Overall signature of acquired KRAS gene changes in advanced non-small cell lung cancer patient with EGFR-TKI resistance. Japanese journal of clinical oncology 2023 9 . Jie Zheng, Yuanyao Dou, Daijuan Huang, Yubo Wang, Rui Han, Chen Hu, Mengxiao Zhu, Conghua Lu, Caiyu Lin, Di Wu, Yihui Liu, Huan Tang, Tingting He, Weilin Jiang, Yong |
| Capmatinib?associated interstitial lung disease in a patient with lung adenocarcinoma harboring a skipping mutation of mesenchymal?epithelial transition exon 14: A case report. Oncology letters 2023 9 26 (4): 455. Bing-Jie Lee, Cheng-Yu Cha |
| IL1RL1 polymorphisms rs12479210 and rs1420101 are associated with increased lung cancer risk in the Chinese Han population. Frontiers in genetics 2023 9 14 1183528. Qi Li, Chan Zhang, Yujing Cheng, Xin Yang, Wanlu Chen, Kunhua He, Mingwei Ch |
| Associations between telomere attrition, genetic variants in telomere maintenance genes, and non-small cell lung cancer risk in the Jammu and Kashmir population of North India. BMC cancer 2023 9 23 (1): 874. Gh Rasool Bhat, Rajeshwer Singh Jamwal, Itty Sethi, Amrita Bhat, Ruchi Shah, Sonali Verma, Minerva Sharma, Hana Q Sadida, Sara K Al-Marzooqi, Tariq Masoodi, Sameer Mirza, Mohammad Haris, Muzafar A Macha, Ammira S Alshabeeb Akil, Ajaz A Bhat, Rakesh Kum |
| Utility of multigene panel next-generation sequencing in routine clinical practice for identifying genomic alterations in newly diagnosed metastatic nonsmall cell lung cancer. Internal medicine journal 2023 9 . Udit Nindra, Abhijit Pal, Victoria Bray, Po Y Yip, Annette Tognela, Tara L Roberts, Therese M Becker, Jonathon Williamson, Mahtab Farzin, Jing J Li, Vivienne Lea, Abeer Hagelamin, Weng Ng, Bin Wang, C Soon Lee, Wei Ch |
| LAPS score for individualized treatment of advanced EGFR-mutated non-small cell lung cancer receiving EGFR-TKIs with or without bevacizumab. Annals of medicine 2023 9 55 (2): 2257227. Yahua Wu, Bin Du, Chengliu Lv, Xiaohui Ji, Jinhuo L |
| The possibility of mutations of RAS signaling genes and/or TP53 in combination as a negative prognostic impact on pathological stage I non-small cell lung cancer. Cancer medicine 2023 9 . Takayuki Honda, Katsutoshi Seto, Satoshi Endo, Akira Takemoto, Kousuke Tanimoto, Masashi Kobayashi, Masatake Kitano, Rie Sakakibara, Takahiro Mitsumura, Hironori Ishibashi, Johji Inazawa, Toshihiro Tanaka, Yasunari Miyazaki, Kenichi Oku |
| Clinical outcomes of advanced NSCLC patients with different EGFR exon 19 deletion subtypes treated with first-line tyrosine kinase inhibitors: A single-center ambispective cohort study. Thoracic cancer 2023 9 . Yangchun Gu, Jinyu Yu, Haifeng Hu, Hua Zhang, Baoshan Cao, Li Lia |
| Clinical significance of DNA damage response mutations in stage I and stage IIIa NSCLC. Thoracic cancer 2023 9 . Haoran Zhang, Dongming Zhang, Jia Liu, Yuequan Shi, Xiaoyan Liu, Minjiang Chen, Wei Zhong, Jing Zhao, Yan Xu, Mengzhao Wa |
| Survival outcomes of east Asian patients with advanced non-small cell lung cancer treated with first-line EGFR tyrosine kinase inhibitors: A network meta-analysis of real-world evidence. Thoracic cancer 2023 9 . Huang-Chih Chang, Kuo-Tung Huang, Chia-Cheng Tseng, Yu-Mu Chen, Chien-Hao Lai, Yu-Ping Chang, Yung-Che Chen, Hung-Yi Chuang, Chin-Chou Wa |
| Clinico-pathological characteristics of IGFR1 and VEGF-A co-expression in early and locally advanced-stage lung adenocarcinoma. Journal of cancer research and clinical oncology 2023 9 . Wenting Liu, Junling Xia, Qingwu Du, Jingya Wang, Ting Mei, Tingting Q |
| Lazertinib Versus Gefitinib Tyrosine Kinase Inhibitors in Treatment-Naíve Patients With EGFR-Mutated Advanced NSCLC: Analysis of the Asian Subpopulation in LASER301. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2023 9 . Thanyanan Reungwetwattana, Byoung Chul Cho, Ki Hyeong Lee, Yong Kek Pang, Chin Heng Fong, Jin Hyoung Kang, Yun-Gyoo Lee, Chun Sen Lim, Pongwut Danchaivijitr, Yueh Ni Lim, Youngjoo Lee, Soon Hin How, Sarayut Geater, Sung Sook Lee, Young Joo Min, Joo-Hang Kim, Jong-Seok Lee, Gyeong-Won Lee, Ross A Soo, Sae Young Lee, SeokYoung Choi, Myung-Ju A |
| The Prognostic and Functional Impact of Sprouty 2 Expression in Non-small Cell Lung Cancer. American journal of clinical oncology 2023 9 . Yusuf Acikgoz, Fatma Unal Yildirim, Selin Akturk Esen, Gokhan Ucar, Yakup Ergun, Oznur Bal, Mutlu Dogan, Dogan Un |
| Efficacy of paclitaxel-carboplatin with bevacizumab as a late-line therapy for patients with advanced nonsquamous non-small cell lung cancer: A platinum rechallenge. Thoracic cancer 2023 9 . Jun Sugisaka, Yukihiro Toi, Yosuke Kawashima, Yutaka Domeki, Tomoiki Aiba, Sachiko Kawana, Atsushi Nakamura, Shinsuke Yamanda, Yuichiro Kimura, Shunichi Sugawa |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: